Literature DB >> 10891326

Sterol 14-demethylase P450 (CYP51) provides a breakthrough for the discussion on the evolution of cytochrome P450 gene superfamily.

Y Yoshida1, Y Aoyama, M Noshiro, O Gotoh.   

Abstract

Biodiversity is the most characteristic feature of cytochrome P450. Finding of CYP51 distributing widely in biological kingdoms provided breakthroughs for the discussion on the evolution and diversification of P450. Molecular phylogenetic analysis demonstrated that CYP51 appeared in the prokaryotic era and distributed into most kingdoms concomitant with phylogenetic divergence. This is the first evolutionary evidence indicating the prokaryotic origin of P450. Modification of substrate specificity of eukaryotic CYP51s occurred independently to adapt to the different sterol precursors existing in each kingdom. Formation of CYP51 variants through the mutation of active site and the selection of the advantageous ones from them were demonstrated by the emergence of azole-resistant CYP51s in Candida albicans under the environments rich in azole antifungal agents. These findings illustrate the most probable core process of P450 diversification consisting of modification of active site and selection of the resulting variants through interaction with endogenous and exogenous chemicals. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891326     DOI: 10.1006/bbrc.2000.3030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; Jialin Liu; W David Nes; Michael R Waterman; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

2.  New aspects on lanosterol 14alpha-demethylase and cytochrome P450 evolution: lanosterol/cycloartenol diversification and lateral transfer.

Authors:  Tadeja Rezen; Natasa Debeljak; Dusan Kordis; Damjana Rozman
Journal:  J Mol Evol       Date:  2004-07       Impact factor: 2.395

Review 3.  Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms.

Authors:  Galina I Lepesheva; Michael R Waterman
Journal:  Biochim Biophys Acta       Date:  2006-08-02

Review 4.  Targeting Trypanosoma cruzi sterol 14α-demethylase (CYP51).

Authors:  Galina I Lepesheva; Fernando Villalta; Michael R Waterman
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

5.  Comparative genomics reveals high biological diversity and specific adaptations in the industrially and medically important fungal genus Aspergillus.

Authors:  Ronald P de Vries; Robert Riley; Ad Wiebenga; Guillermo Aguilar-Osorio; Sotiris Amillis; Cristiane Akemi Uchima; Gregor Anderluh; Mojtaba Asadollahi; Marion Askin; Kerrie Barry; Evy Battaglia; Özgür Bayram; Tiziano Benocci; Susanna A Braus-Stromeyer; Camila Caldana; David Cánovas; Gustavo C Cerqueira; Fusheng Chen; Wanping Chen; Cindy Choi; Alicia Clum; Renato Augusto Corrêa Dos Santos; André Ricardo de Lima Damásio; George Diallinas; Tamás Emri; Erzsébet Fekete; Michel Flipphi; Susanne Freyberg; Antonia Gallo; Christos Gournas; Rob Habgood; Matthieu Hainaut; María Laura Harispe; Bernard Henrissat; Kristiina S Hildén; Ryan Hope; Abeer Hossain; Eugenia Karabika; Levente Karaffa; Zsolt Karányi; Nada Kraševec; Alan Kuo; Harald Kusch; Kurt LaButti; Ellen L Lagendijk; Alla Lapidus; Anthony Levasseur; Erika Lindquist; Anna Lipzen; Antonio F Logrieco; Andrew MacCabe; Miia R Mäkelä; Iran Malavazi; Petter Melin; Vera Meyer; Natalia Mielnichuk; Márton Miskei; Ákos P Molnár; Giuseppina Mulé; Chew Yee Ngan; Margarita Orejas; Erzsébet Orosz; Jean Paul Ouedraogo; Karin M Overkamp; Hee-Soo Park; Giancarlo Perrone; Francois Piumi; Peter J Punt; Arthur F J Ram; Ana Ramón; Stefan Rauscher; Eric Record; Diego Mauricio Riaño-Pachón; Vincent Robert; Julian Röhrig; Roberto Ruller; Asaf Salamov; Nadhira S Salih; Rob A Samson; Erzsébet Sándor; Manuel Sanguinetti; Tabea Schütze; Kristina Sepčić; Ekaterina Shelest; Gavin Sherlock; Vicky Sophianopoulou; Fabio M Squina; Hui Sun; Antonia Susca; Richard B Todd; Adrian Tsang; Shiela E Unkles; Nathalie van de Wiele; Diana van Rossen-Uffink; Juliana Velasco de Castro Oliveira; Tammi C Vesth; Jaap Visser; Jae-Hyuk Yu; Miaomiao Zhou; Mikael R Andersen; David B Archer; Scott E Baker; Isabelle Benoit; Axel A Brakhage; Gerhard H Braus; Reinhard Fischer; Jens C Frisvad; Gustavo H Goldman; Jos Houbraken; Berl Oakley; István Pócsi; Claudio Scazzocchio; Bernhard Seiboth; Patricia A vanKuyk; Jennifer Wortman; Paul S Dyer; Igor V Grigoriev
Journal:  Genome Biol       Date:  2017-02-14       Impact factor: 13.583

6.  The cytochrome P450 genesis locus: the origin and evolution of animal cytochrome P450s.

Authors:  David R Nelson; Jared V Goldstone; John J Stegeman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

7.  Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.

Authors:  Stephanie A Flowers; Brendan Colón; Sarah G Whaley; Mary A Schuler; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

Review 8.  Adaptive evolution of mammalian aromatases: lessons from Suiformes.

Authors:  A J Conley; C J Corbin; A L Hughes
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2009-06-01

9.  Identification, modeling and ligand affinity of early deuterostome CYP51s, and functional characterization of recombinant zebrafish sterol 14α-demethylase.

Authors:  Ann Michelle Stanley Morrison; Jared V Goldstone; David C Lamb; Akira Kubota; Benjamin Lemaire; John J Stegeman
Journal:  Biochim Biophys Acta       Date:  2013-12-19

10.  Cloning and characterization of CYP51 from Mycobacterium avium.

Authors:  Michael P Pietila; Pawan K Vohra; Bharati Sanyal; Nancy L Wengenack; Sreekumar Raghavakaimal; Charles F Thomas
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-16       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.